Mitchell Levine

Mitchell Levine

Chairman at IMMUNOPRECISE ANTIBODIES LTD.

Net worth: 30 400 $ as of 2024-03-30

Finance
Health Technology
Consumer Services

Mitchell Levine active positions

CompaniesPositionStartEnd
IMMUNOPRECISE ANTIBODIES LTD. Chairman 2023-11-26 -
Director/Board Member - 2023-11-26
Chief Executive Officer 2022-10-31 -
Chairman - -

Career history of Mitchell Levine

Former positions of Mitchell Levine

CompaniesPositionStartEnd
Chief Investment Officer 2001-12-31 2016-12-31
Compliance Officer 2001-12-31 2016-12-31
Founder 2011-07-26 2016-12-31
Cove Capital Advisors, Inc. Corporate Officer/Principal - -
ONCOCYTE CORPORATION Director of Finance/CFO 2017-11-14 2022-05-31
Corporate Officer/Principal 2022-05-31 -
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -

Training of Mitchell Levine

University of California, Davis Undergraduate Degree

Statistics

International

United States 9
Canada 2

Operational

Corporate Officer/Principal 5
Chairman 2
Chief Investment Officer 1

Sectoral

Finance 4
Health Technology 4
Consumer Services 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Private companies6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW